Multicenter phase II study of docetaxel and cisplatin as primary chemotherapy in patients with stage Ic-IV epithelial ovarian cancer
Phase 2
- Conditions
- Stage Ic-IV epithelial ovarian cancer
- Registration Number
- JPRN-UMIN000000550
- Lead Sponsor
- A group for a study of DOC/CDDP combination chemotherapy for ovarian cancer
- Brief Summary
Presented at the 44th Annual Meeting of Japan Society of Clinical Oncology (October 18th to 20th 2006)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Received only exploratory laparotomy 2.Confirmed infection 3.Fever (a body temperature >= 38 degrees Celsius) 4.Severe complication 5.Active concomitant malignancy 6.Brain metastasis 7.Interstitial pneumonia or lung fibrosis confirmed by chest X-ray or computed tomography 8.Pleural or peritoneal effusion that required treatment 9.Pericardial effusion 10.Motor paralysis, peripheral nervous system dysfunction or edema of grade 2 or more 11.History of severe drug allergy 12.Previously received long-term corticosteroid therapy 13.Pregnant or lactating women, or women who intended to become pregnant during the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival
- Secondary Outcome Measures
Name Time Method Safety, feasibility, clinical response, overall survival